Treatment With Acamprosate in Patients With Schizophrenia Spectrum Disorders and Comorbid Alcohol Dependence

REFERENCES

• Allebeck , P. , Varla , A. , Kristjansson , E. and Wistedt , B. 1987 . Risk factors for suicide among patients with schizophrenia . Acta Psychiatrica Scandinavica , 76 ( 4 ) : 414 – 419 .
   PubMed Web of Science ®Google Scholar
• Anton , R. F. , Moak , D. H. and Latham , P. 1995 . The Obsessive Compulsive Drinking Scale: A self-rated instrument for the quantification of thoughts about alcohol and drinking behavior . Alcoholism: Clinical & Experimental Research , 19 ( 1 ) : 92 – 99 .
   PubMed Web of Science ®Google Scholar
• Anton , R. F. , O’Malley , S. S. , Ciraulo , D. A. , Cisler , R. A. , Couper , D. , Donovan , D. M. and …Group , C. S. R. 2006 . Combined pharmacotherapies and behavioral interventions for alcohol dependence: The COMBINE study: A randomized controlled trial . Journal of the American Medical Association , 295 ( 17 ) : 2003 – 2017 .
   PubMed Web of Science ®Google Scholar
• Bogenschutz , M. P. 2005 . Specialized 12-step programs and 12-step facilitation for the dually diagnosed . Community Mental Health Journal , 41 ( 1 ) : 7 – 20 .
   PubMed Web of Science ®Google Scholar
• Brunette , M. F. , Drake , R. E. , Lynde , D. and Group , I. 2002 . Toolkit for integrated dual disorders treatment , Rockville , MD : Substance Abuse and Mental Health Services Administration .
   Google Scholar
• Caton , C. L. , Shrout , P. E. , Dominguez , B. , Eagle , P. F. , Opler , L. A. and Cournos , F. 1995 . Risk factors for homelessness among women with schizophrenia . American Journal of Public Health , 85 ( 8 ) : 1153 – 1156 .
   PubMed Web of Science ®Google Scholar
• Drake , R. E. and Brunette , M. F. 1998 . Complications of severe mental illness related to alcohol and drug use disorders . Recent Developments in Alcoholism , 14 : 285 – 299 .
   PubMedGoogle Scholar
• Drake , R. E. , Essock , S. M. , Shaner , A. , Carey , K. B. , Minkoff , K. , Kola , L. and …Rickards , L. 2001 . Implementing dual diagnosis services for clients with severe mental illness . Psychiatric Services , 52 : 469 – 476 .
   PubMed Web of Science ®Google Scholar
• Drake , R. E. , Mueser , K. T. , Clark , R. E. and Wallach , M. A. 1996 . The course, treatment, and outcome of substance disorder in persons with severe mental illness . American Journal of Orthopsychiatry , 66 ( 1 ) : 42 – 51 .
   PubMed Web of Science ®Google Scholar
• D’Souza , D. C. , Gil , R. B. , Madonick , S. , Perry , E. B. , Forselius-Bielen , K. , Bradley , G. and …Krystal , J. H. 2006 . Enhanced sensitivity to the euphoric effects of alcohol in schizophrenia . Neuropsychopharmacology , 31 ( 12 ) : 2767 – 2775 .
   PubMed Web of Science ®Google Scholar
• First , M. B. , Spitzer , R. L. , Gibbon , M. and Williams , J. B. W. 1996 . Structured Clinical Interview for DSM-IV Axis I Disorders (Patient Edition) (SCID-P) , New York , NY : Biometric Research, New York State Psychiatric Institute .
   Google Scholar
• Food and Drug Administration . 2004 . Center for Drug Evaluation and Research approval package for: Application number 21–431 Retrieved from http://www.accessdata.fda.gov/drugsatfda_docs/nda/2004/21-431_Campral_AdminCorres_P1.pdf
   Google Scholar
• Hansen , L. and Larsen , N. 1982 . Metabolic interaction between perphenazine and disulfiram . Lancet , 2 ( 8313 ) : 1472
   PubMed Web of Science ®Google Scholar
• Kay , S. , Fiszbein , A. and Opler , L. 1987 . The Positive and Negative Syndrome Scale (PANSS) for schizophrenia . Schizophrenia Bulletin , 13 : 261 – 276 .
   PubMed Web of Science ®Google Scholar
• Krystal , J. H. , Petrakis , I. L. , Limoncelli , D. , Webb , E. , Gueorguieva , R. , D’Souza , D. C. and …Charney , D. S. 2003 . Altered NMDA glutamate receptor antagonist response in recovering ethanol-dependent patients . Neuropsychopharmacology , 28 ( 11 ) : 2020 – 2028 .
   PubMed Web of Science ®Google Scholar
• Littleton , J. M. 2007 . Acamprosate in alcohol dependence: Implications of a unique mechanism of action . Journal of Addiction Medicine , 1 ( 3 ) : 115 – 125 .
   PubMed Web of Science ®Google Scholar
• Mason , B. 2001 . Treatment of alcohol-dependent outpatients with acamprosate: A clinical review . Journal of Clinical Psychiatry , 62 ( 20 ) : 42 – 48 .
   PubMed Web of Science ®Google Scholar
• Mason , B. J. and Heyser , C. J. 2010 . The neurobiology, clinical efficacy and safety of acamprosate in the treatment of alcohol dependence . Expert Opinion on Drug Safety , 9 : 177 – 188 .
   PubMed Web of Science ®Google Scholar
• Moghaddam , B. 2003 . Bringing order to the glutamate chaos in schizophrenia . Neuron , 40 : 881 – 884 .
   PubMed Web of Science ®Google Scholar
• Mueser , K. T. , Noordsy , D. L. , Drake , R. E. and Fox , L. 2003 . Integrated treatment for dual disorders: A guide to effective practice , New York , NY : Guilford .
   Google Scholar
• Owen , R. R. , Fischer , E. P. , Booth , B. M. and Cuffel , B. J. 1996 . Medication noncompliance and substance abuse among patients with schizophrenia . Psychiatric Services , 47 ( 8 ) : 853 – 858 .
   PubMed Web of Science ®Google Scholar
• Paz , R. D. , Tardito , S. , Atzori , M. and Tseng , K. Y. 2008 . Glutamatergic dysfunction in schizophrenia: From basic neuroscience to clinical psychopharmacology . European Neuropsychopharmacology , 18 : 773 – 786 .
   PubMed Web of Science ®Google Scholar
• Petrakis , I. L. , O’Malley , S. , Rounsaville , B. , Poling , J. , McHugh-Strong , C. and Krystal , J. H. 2004 . Naltrexone augmentation of neuroleptic treatment in alcohol abusing patients with schizophrenia . Psychopharmacology , 172 : 291 – 297 .
   PubMed Web of Science ®Google Scholar
• Petrakis , I. L. , Poling , J. , Levinson , C. , Nich , C. and Rounsaville , B. 2005 . Naltrexone and disulfiram in patients with alcohol dependence and comorbid psychiatric disorders . Biological Psychiatry , 57 : 1128 – 1137 .
   PubMed Web of Science ®Google Scholar
• Regier , D. A. , Farmer , M. E. and Rae , D. S. 1990 . Comorbidity of mental disorders with alcohol and other drug abuse. Results from the Epidemiological Catchment Area (ECA) study . Journal of the American Medical Association , 264 ( 19 ) : 2511 – 2518 .
   PubMed Web of Science ®Google Scholar
• Sobell , L. C. and Sobell , M. B. 1992 . “ Timeline Follow-Back: A technique for assessing self-reported alcohol consumption ” . In Measuring alcohol consumption: Psychosocial and biological methods , Edited by: Litten , R. Z. and Allen , J. 41 – 72 . Totowa , NJ : Humana Press .
   Google Scholar
• Sullivan , G. , Wells , K. B. , Morgenstern , H. and Leake , B. 1995 . Identifying modifiable risk factors for rehospitalization: A case-control study of seriously mentally ill persons in Mississippi . American Journal of Psychiatry , 152 ( 12 ) : 1749 – 1756 .
   PubMed Web of Science ®Google Scholar
• Swanson , J. W. , Holzer , C. E. 3rd , Ganju , V. K. and Jono , R. T. 1990 . Violence and psychiatric disorder in the community: Evidence from the Epidemiologic Catchment Area surveys . Hospital & Community Psychiatry , 41 ( 7 ) : 761 – 770 .
   PubMedGoogle Scholar
• Tiffany , S. T. and Conklin , C. A. 2000 . A cognitive processing model of alcohol craving and compulsive alcohol use . Addiction , 95 ( 2 ) : S145 – S153 .
   PubMed Web of Science ®Google Scholar
• Tracy , J. I. , Oesterling , R. and Josiassen , R. C. 1995 . Transient fluctuations in cognitive functioning in schizophrenia based on single-case study methods . Schizophrenia Research , 17 ( 2 ) : 201 – 209 .
   PubMed Web of Science ®Google Scholar
• Wobrock , T. and Soyka , M. 2008 . Pharmacotherapy of schizophrenia with comorbid substance use disorder: Reviewing the evidence and clinical recommendations . Progress in Neuro Psychopharmacology & Biological Psychiatry , 32 ( 6 ) : 1375 – 1385 .
   PubMed Web of Science ®Google Scholar